Edgewise Therapeutics, Inc. — Director's Dealing 2021

Oct 6, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Edgewise Therapeutics, Inc. (EWTX)
CIK: 0001710072
Period of Report: 2021-10-01

Reporting Person: Russell Alan J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-01	Common Stock	S	274.00	$18.00	Disposed	178826.00	Direct
2021-10-04	Common Stock	S	100.00	$18.00	Disposed	178726.00	Direct
2021-10-05	Common Stock	S	5404.00	$18.26	Disposed	173322.00	Direct

Footnotes

F1: The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.75, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.